Aemetis (NASDAQ:AMTX) Releases Quarterly Earnings Results, Beats Expectations By $0.18 EPS

Aemetis (NASDAQ:AMTX) issued its quarterly earnings results on Thursday. The specialty chemicals company reported ($0.02) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.20) by $0.18, FiscalAI reports. The company had revenue of $88.15 million for the quarter, compared to analysts’ expectations of $74.20 million.

Here are the key takeaways from Aemetis’ conference call:

• Third-quarter results improved sharply: revenue rose 49% year over year to $88.2 million, net income was $5.2 million, and Adjusted EBITDA reached $24.8 million, versus a loss in both measures a year earlier. Results included $24.7 million in 45Z tax-credit revenue, including an $11 million catch-up adjustment, so reported performance was partly driven by credits.
• Aemetis said seven dairy RNG pathways averaging a carbon-intensity score of negative 380 are approved, with six more pending, supporting greater LCFS credit generation. The company also reported 14 operating digesters and said production has exceeded its forecasts, though further growth depends in part on new pathway approvals and financing.
• The Keyes ethanol plant’s MVR project is expected by management to add about $32 million in annual cash flow through lower natural-gas use and higher-value credits. Construction is progressing, but completion is targeted for the first half of 2027 and management expects most financial benefits in the second half, subject to commissioning.
• Quarter-end cash was $3.4 million after $20.2 million of quarterly capital investment; the company also received $22.4 million from selling 45Z credits. A biogas preferred-unit redemption date was extended to December 31, 2026, highlighting ongoing funding and liquidity considerations.
• India biodiesel sales rebounded to $7.3 million as deliveries resumed under a $17 million allocation, and the company expects export approvals for Europe in the fourth quarter. Management cited potential access to its 80-million-gallon capacity, but noted practical supply-chain limits and did not expect long-term offtake contracts.

Aemetis Stock Performance

NASDAQ AMTX traded up $0.48 during trading on Thursday, hitting $1.73. 16,538,026 shares of the company’s stock traded hands, compared to its average volume of 825,822. The stock has a market capitalization of $124.85 million, a price-to-earnings ratio of -1.90 and a beta of 1.87. Aemetis has a 12-month low of $1.11 and a 12-month high of $3.80. The business has a 50 day moving average of $1.67 and a 200-day moving average of $1.94.

Key Aemetis News

Here are the key news stories impacting Aemetis this week:

• Positive Sentiment: Third-quarter revenue increased 49% year over year to $88.2 million, while the company reported $5.2 million in net income and $24.8 million in adjusted EBITDA. Operating income improved by $29.4 million year over year. Aemetis Q3 2026 financial results
• Positive Sentiment: Per-share results also beat analyst expectations: Aemetis reported a $0.02 quarterly loss versus the consensus estimate of a $0.20 loss, and improved from a $0.37 loss a year earlier. Revenue of $88.15 million topped the $74.20 million estimate. Aemetis Q3 loss and revenue estimates
• Positive Sentiment: Section 45Z production tax credit income was $24.7 million, including an approximately $11 million catch-up adjustment after an updated federal model. Aemetis also expects its MVR project to generate $32 million in annual cash flow in 2027 as 45Z values reset higher, adding a potential future earnings and cash-flow driver. Aemetis MVR and 45Z outlook
• Positive Sentiment: Biogas renewable natural gas sales volume grew 39% year over year to 158,200 MMBtu. Two new dairy digesters began operating in October, expanding the network to 14 digesters serving 17 dairies. Aemetis Q3 2026 financial results

Analysts Set New Price Targets

Several equities analysts have weighed in on AMTX shares. Weiss Ratings reissued a “sell (e+)” rating on shares of Aemetis in a report on Thursday, October 15th. Wall Street Zen raised Aemetis from a “sell” rating to a “hold” rating in a research report on Saturday, August 22nd. One analyst has rated the stock with a Buy rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the company has an average rating of “Hold” and a consensus price target of $11.88.

About Aemetis

Aemetis, Inc is a renewable fuels and carbon-reduction company that develops and operates projects designed to produce lower-carbon alternatives to petroleum-based fuels and reduce greenhouse-gas emissions. Its activities include renewable natural gas, ethanol, renewable diesel, and other advanced fuel technologies.

The company’s California operations include dairy-based renewable natural gas projects that capture methane from dairy waste and convert it into pipeline-quality fuel. Aemetis also operates an ethanol production facility in Keyes, California, which produces ethanol and related co-products from agricultural feedstocks.